Optical Coherence Tomography Angiography versus Fundus Fluorescein Angiography in Assessment of Clinically Undetected Neovascularization in Severe Non-Proliferative Diabetic Retinopathy Patients
MOHAMMED H. HASHEM, M.D., H., YOUSTIENA R. MORIES, M.Sc., N. (2021). Optical Coherence Tomography Angiography versus Fundus Fluorescein Angiography in Assessment of Clinically Undetected Neovascularization in Severe Non-Proliferative Diabetic Retinopathy Patients. EKB Journal Management System, 89(December), 2791-2799. doi: 10.21608/mjcu.2021.225182
HUSSEIN Sh. EL MARKAPY, M.D.; MOHAMMED H. HASHEM, M.D.; NOURELDIN H. ABOZEID, M.D.; YOUSTIENA R. MORIES, M.Sc.. "Optical Coherence Tomography Angiography versus Fundus Fluorescein Angiography in Assessment of Clinically Undetected Neovascularization in Severe Non-Proliferative Diabetic Retinopathy Patients". EKB Journal Management System, 89, December, 2021, 2791-2799. doi: 10.21608/mjcu.2021.225182
MOHAMMED H. HASHEM, M.D., H., YOUSTIENA R. MORIES, M.Sc., N. (2021). 'Optical Coherence Tomography Angiography versus Fundus Fluorescein Angiography in Assessment of Clinically Undetected Neovascularization in Severe Non-Proliferative Diabetic Retinopathy Patients', EKB Journal Management System, 89(December), pp. 2791-2799. doi: 10.21608/mjcu.2021.225182
MOHAMMED H. HASHEM, M.D., H., YOUSTIENA R. MORIES, M.Sc., N. Optical Coherence Tomography Angiography versus Fundus Fluorescein Angiography in Assessment of Clinically Undetected Neovascularization in Severe Non-Proliferative Diabetic Retinopathy Patients. EKB Journal Management System, 2021; 89(December): 2791-2799. doi: 10.21608/mjcu.2021.225182